V-504

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameV-504
Drug Alias NameHuman papillomavirus vaccine recombinant pentavalent (Merck & Co)V-504
ClassificationVaccines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVulvar NeoplasmsVaginal NeoplasmsUterine Cervical Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsVulvar NeoplasmsVaginal NeoplasmsUterine Cervical Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A